Sponsor

Supernus Pharmaceuticals, Inc.

Clinical research sponsor

Published trials12
Recruiting shown2
Roles2
SourceClinicalTrials.gov

Clinical trials

12 shown
Double-blind, Placebo-controlled Study in Adults With Major Depressive DisorderNCT07226661 · lead sponsor · 2026-01-19
RECRUITING
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:NCT07219927 · lead sponsor · 2025-03-31
RECRUITING
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)NCT05619692 · lead sponsor · 2022-11-29
COMPLETED
A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive ImpairmentNCT05318937 · lead sponsor · 2022-06-06
COMPLETED
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)NCT04602624 · lead sponsor · 2020-12-07
COMPLETED
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)NCT04476017 · lead sponsor · 2020-07-31
COMPLETED
Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)NCT03944785 · lead sponsor · 2017-11-30
COMPLETED
A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)NCT02942004 · lead sponsor · 2016-08-01
COMPLETED
A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)NCT02942017 · lead sponsor · 2016-07-01
COMPLETED
A Study to Evaluate SAGE-547 in Participants With Severe Postpartum DepressionNCT02614547 · lead sponsor · 2015-12-15
COMPLETED
Evaluate SAGE-547 in Female Participants With Severe Postpartum DepressionNCT02285504 · lead sponsor · 2015-01-07
COMPLETED
Open-Label of SPN-820 in Adults With Major Depressive DisorderNCT06235905 · collaborator · 2024-02-15
COMPLETED

Sponsor roles

lead sponsor11
collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.